DiscoveryMAP v. 3.3 is a comprehensive, quantitative, immunoassay service product, measuring a comprehensive set of our human assays. It is the culmination of 15 years of assay development for cytokines, chemokines, metabolic markers, hormones, growth factors, tissue remodeling proteins, angiogenesis markers, acute phase reactants, cancer markers, kidney damage markers, CNS biomarkers and other important circulating proteins. DiscoveryMAP v. 3.3 is for those who seek a thorough understanding of a compound’s biological activity, efficacy, and safety profile as well as the disease or condition being addressed.
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
A portion of these assays use antibodies provided by the National Cancer Institute’s Clinical Proteomic Technologies for Cancer.
Click here for more details regarding materials used in these assays.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|650 µL||3 mL|